ATXN7 Gene Spinocerebellar Ataxia Type 7 Autosomal Dominant Genetic Test sale cost 4400 AED
WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test sale cost 4400 AED WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CSTB Gene Unverricht-Lundborg Disease Genetic Test sale cost 4400 AED CSTB Gene Unverricht-Lundborg Disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ATXN7 Gene Spinocerebellar Ataxia Type 7 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATXN7 gene spinocerebellar ataxia type 7 (SCA7) autosomal dominant genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ATXN7 gene, which are known to cause spinocerebellar ataxia type 7. This condition is characterized by progressive deterioration of motor skills, coordination, and vision, resulting from the degeneration of specific areas in the cerebellum and retina. As an autosomal dominant disorder, only one copy of the mutated gene inherited from an affected parent is sufficient to cause the condition.

This genetic test involves analyzing the patient’s DNA, extracted from a blood sample, to look for specific mutations in the ATXN7 gene that are indicative of SCA7. The process is vital for individuals with a family history of the condition or those exhibiting symptoms, as it can confirm the diagnosis, inform about the progression of the disease, and aid in family planning decisions.

The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the procedure and the sophisticated technology employed. Upon completion, the results provide crucial information for the management and treatment of affected individuals, offering them and their families a clearer understanding of the condition and how to navigate its challenges.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATXN7 Gene Spinocerebellar ataxia type 7 autosomal dominant Genetic Test

Cost: AED 4400.0

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ATXN7 Gene Spinocerebellar ataxia type 7, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN7 Gene Spinocerebellar ataxia type 7, autosomal dominant.

Test Details

The ATXN7 gene is associated with Spinocerebellar ataxia type 7 (SCA7), an autosomal dominant neurodegenerative disorder. Next-generation sequencing (NGS) genetic tests can be used to analyze the ATXN7 gene for mutations or variations that may be linked to SCA7.

NGS genetic tests involve sequencing the DNA of an individual to identify any changes or variations in specific genes. In the case of SCA7, NGS can be used to analyze the ATXN7 gene for expansions of a specific trinucleotide repeat sequence (CAG) within the gene. The number of CAG repeats in the gene is directly related to the severity and onset of SCA7 symptoms.

NGS genetic tests for SCA7 can help in confirming a diagnosis, predicting the age of onset, and assessing the risk of passing the condition to future generations. These tests are typically performed by specialized laboratories and require a sample of the individual’s DNA, usually obtained through a blood or saliva sample.

It is important to note that genetic testing for SCA7 should be done under the guidance of a healthcare professional or genetic counselor, as the results can have significant implications for the individual and their family.

Test Name ATXN7 Gene Spinocerebellar ataxia type 7 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATXN7 Gene Spinocerebellar ataxia type 7, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN7 Gene Spinocerebellar ataxia type 7, autosomal dominant
Test Details

ATXN7 gene is associated with Spinocerebellar ataxia type 7 (SCA7), an autosomal dominant neurodegenerative disorder. Next-generation sequencing (NGS) genetic tests can be used to analyze the ATXN7 gene for mutations or variations that may be linked to SCA7.

NGS genetic tests involve sequencing the DNA of an individual to identify any changes or variations in specific genes. In the case of SCA7, NGS can be used to analyze the ATXN7 gene for expansions of a specific trinucleotide repeat sequence (CAG) within the gene. The number of CAG repeats in the gene is directly related to the severity and onset of SCA7 symptoms.

NGS genetic tests for SCA7 can help in confirming a diagnosis, predicting the age of onset, and assessing the risk of passing the condition to future generations. These tests are typically performed by specialized laboratories and require a sample of the individual’s DNA, usually obtained through a blood or saliva sample.

It is important to note that genetic testing for SCA7 should be done under the guidance of a healthcare professional or genetic counselor, as the results can have significant implications for the individual and their family.

SKU: TEST-2079 Category:

Related products